7-nitroindazole has been researched along with Parkinsonian Disorders in 5 studies
7-nitroindazole: an inhibitor of nitric oxide synthase; exhibits anti-nociceptive activity without increasing blood pressure
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herrero, MT | 1 |
| Yuste, JE | 1 |
| Cuenca-Bermejo, L | 1 |
| Almela, P | 1 |
| Arenas-Betancur, L | 1 |
| De Pablos, V | 1 |
| Gonzalez-Cuello, A | 1 |
| Del Bel, E | 1 |
| Navarro-Zaragoza, J | 1 |
| Fernández-Villalba, E | 1 |
| Takuma, K | 1 |
| Tanaka, T | 1 |
| Takahashi, T | 1 |
| Hiramatsu, N | 1 |
| Ota, Y | 1 |
| Ago, Y | 1 |
| Matsuda, T | 1 |
| Chalimoniuk, M | 1 |
| Lukacova, N | 1 |
| Marsala, J | 1 |
| Langfort, J | 1 |
| Thomas, B | 1 |
| Saravanan, KS | 1 |
| Mohanakumar, KP | 1 |
| Yokoyama, H | 1 |
| Takagi, S | 1 |
| Watanabe, Y | 1 |
| Kato, H | 1 |
| Araki, T | 1 |
5 other studies available for 7-nitroindazole and Parkinsonian Disorders
| Article | Year |
|---|---|
7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate.
Topics: Animals; Antiparkinson Agents; Dyskinesia, Drug-Induced; Levodopa; Parkinson Disease; Parkinsonian D | 2023 |
Neuronal nitric oxide synthase inhibition attenuates the development of L-DOPA-induced dyskinesia in hemi-Parkinsonian rats.
Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Dopamine and cAMP-Regulated Phosphoprotein 32 | 2012 |
Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Cell Count; Cyclic GMP; | 2006 |
In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole.
Topics: Animals; Antioxidants; Basal Ganglia; Brain; Catalase; Cytoprotection; Enzyme Inhibitors; Glutathion | 2008 |
Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Cytoprotectio | 2008 |